Skip to main content

Table 3 Cox univariate models for time to progression and overall survival a

From: TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group

    Time to progression     Overall survival   
Risk factor n HR 95% CI   P HR 95% CI   P
TIMP-1 (positive vs. negative) 264 0.90 (0.61- 1.31) 0.57 0.742 (0.55- 1.01) 0.06
  1. aModels not stratified.
  2. Abbreviations: CI Confidence interval, HR Hazard ratio, TIMP-1 Tissue inhibitor of metalloproteinases-1.